Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Mparmparousi D"'
Autor:
Kotsianidis, I., Hatzimichael, E., Pappa, V., Galanopoulos, A., Kourakli, A., Diamantopoulos, P., Papageorgiou, S., Liapis, K., Papadopoulos, V., Papoutselis, M., Bouchla, A., Georgoulis, V., Vassilakopoulos, T., Solomou, E., Dimou, M., Vassilopoulos, G., Vardi, A., Papaioannou, M., Pontikoglou, C., Anagnostopoulos, A., Panayiotidis, P., Kontopidou, F., Harchalakis, N., Adamopoulos, N., Ximeri, M., Zikos, P., Megalakaki, A., Repousis, P., Kotsopoulou, M., Dryllis, G., Tsoukanas, D., Kyrtsonis, M.-C., Poulakidas, E., Bouronikou, E., Delimpasis, S., Mparmparousi, D., Papadaki, H., Vyniou, N.A., Symeonidis, A.
Publikováno v:
In Leukemia Research May 2023 128 Supplement
Transplant-ineligible relapsed/refractory (rr) diffuse large B-cell lymphoma (DLBCL) patients represent an unmet medical need. Polatuzumab vedotin (Pola), an anti-CD79b antibody-drug-conjugate (ADG), with bendamustine- rituximab(BR) has recently gain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::fe73a15e7db58341a50f122221c530c5
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3076389
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3076389
Introduction: Patients relapsing early after autologous stem cell transplantation (ASCT) are a particular therapeutic challenge. Methods: This was a retrospective, single center study that included 297 consecutive patients that received first-line AS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::cc27d50801f8ef8d7d702f7484d01729
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3078151
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3078151
Background: 5-azacytidine (5-AZA) improves survival of patients with higher-risk myelodysplastic syndromes (MDSs) and oligoblastic acute myeloid leukemia (AML); however, predictive factors for response and outcome have not been consistently studied.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::2f1346cbba3a388fdd0c272409f84d91
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3104904
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3104904
In patients with myelodysplastic syndrome (MDS), the prognostic significance of chromosome 17 abnormalities has not yet been fully elucidated, except for isochromosome 17q that has been characterized as an intermediate risk abnormality in the Revised
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::ce5198a9deb75623d6bd5a5afc708c09
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3078566
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3078566
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
The demethylating factor 5-azacytidine (5-AZA) improves survival in intermediate-2 and high-risk myelodysplastic syndrome (MDS) patients [according to the International Prognostic Score System (IPSS)] responding to treatment. However, the outcome of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::224499392c34225e5bdf35d20b7ae8bd
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3086564
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3086564
In this study, we investigated the incidence and prognostic impact of monosomal karyotype (MK) in 405 higher-risk Myelodysplastic Syndromes (MDS) patients treated with 5-AZA. The MK was present in 66 out of 405 (16.3%) patients, most of whom had comp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::8c977081807354576443849bb9bd354f
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3107292
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3107292
Renal failure (RF) is a common and severe complication of symptomatic myeloma, associated with significant morbidity and mortality. Such patients are commonly excluded from clinical trials. Bortezomib/dexamethasone (VD)-based regimens are the backbon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::488f8a7bbc77ceafe5dca34e36443678
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3101166
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3101166